0000905148-25-004126.txt : 20251118 0000905148-25-004126.hdr.sgml : 20251118 20251118160733 ACCESSION NUMBER: 0000905148-25-004126 CONFORMED SUBMISSION TYPE: SCHEDULE 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20251118 DATE AS OF CHANGE: 20251118 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Keros Therapeutics, Inc. CENTRAL INDEX KEY: 0001664710 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 811173868 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-91484 FILM NUMBER: 251494668 BUSINESS ADDRESS: STREET 1: 1050 WALTHAM STREET, SUITE 302 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-314-6297 MAIL ADDRESS: STREET 1: 1050 WALTHAM STREET, SUITE 302 CITY: LEXINGTON STATE: MA ZIP: 02421 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ExodusPoint Capital Management, LP CENTRAL INDEX KEY: 0001736225 ORGANIZATION NAME: EIN: 371875900 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G BUSINESS ADDRESS: STREET 1: 65 E 55TH STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 6469409426 MAIL ADDRESS: STREET 1: 65 E 55TH STREET STREET 2: 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 SCHEDULE 13G 1 primary_doc.xml SCHEDULE 13G 0001736225 XXXXXXXX LIVE Common Stock, $0.0001 par value per share 11/10/2025 0001664710 Keros Therapeutics, Inc. 492327101 1050 Waltham Street Suite 302 Lexington MA 02421 Rule 13d-1(c) ExodusPoint Capital Management, LP b DE 0 1907899 0 1907899 1907899 N 6.3 IA PN ExodusPoint Capital Partners GP, LLC b DE 0 1907899 0 1907899 1907899 N 6.3 CO HC Michael Gelband b X1 0 1907899 0 1907899 1907899 N 6.3 IN HC Keros Therapeutics, Inc. 1050 Waltham Street, Suite 302, Lexington, Massachusetts, 02421 This statement is filed by (each, a "Reporting Person" and, collectively, the "Reporting Persons"): (i) ExodusPoint Capital Management, LP ("ExodusPoint Capital Management") with respect to shares of Common Stock, $0.0001 par value per share ("Shares") of the Issuer held by ExodusPoint Partners Master Fund, LP, an investment fund it manages ("ExodusPoint Master Fund"); (ii) ExodusPoint Capital Partners GP, LLC ("ExodusPoint Capital Partners") with respect to Shares held by ExodusPoint Master Fund; and (iii) Michael Gelband ("Mr. Gelband"), with respect to Shares beneficially owned by ExodusPoint Capital Management and ExodusPoint Capital Partners. ExodusPoint Capital Management, ExodusPoint Capital Partners, and Mr. Gelband have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 1, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. The address of the principal business office of ExodusPoint Capital Management, ExodusPoint Capital Partners, and Mr. Gelband is 65 East 55th Street, New York, NY 10022. ExodusPoint Capital Management is a Delaware limited partnership. ExodusPoint Capital Partners is a Delaware limited liability company. Mr. Gelband is a United States citizen. Y As of November 17, 2025, each of the Reporting Persons may be deemed the beneficial owner of 1,907,899 Shares, which are held directly by ExodusPoint Master Fund. ExodusPoint Capital Management, ExodusPoint Capital Partners, and Mr. Gelband directly own no Shares. Pursuant to an investment management agreement, ExodusPoint Capital Management maintains investment and voting power with respect to the securities held by ExodusPoint Master Fund. ExodusPoint Capital Partners is the general partner of ExodusPoint Capital Management. Mr. Gelband controls each of ExodusPoint Capital Management and ExodusPoint Capital Partners. As of November 17, 2025, each of the Reporting Persons may be deemed to beneficially own approximately 6.3% of the Shares outstanding. 0.00 1,907,899.00 0.00 1,907,899.00 Y N ExodusPoint Master Fund has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Shares reported herein. N See disclosure in Item 4 hereof. Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 1: Joint Filing Agreement, dated November 18, 2025 ExodusPoint Capital Management, LP /s/ Timothy Cruise Timothy Cruise, Authorized Signatory 11/18/2025 ExodusPoint Capital Partners GP, LLC /s/ Timothy Cruise Timothy Cruise, Authorized Signatory 11/18/2025 Michael Gelband /s/ Michael Gelband Michael Gelband 11/18/2025 EX-1 2 jointfilingagreement.htm



EXHIBIT 1

JOINT FILING AGREEMENT
PURSUANT TO RULE 13d-1(k)
 
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

Dated: November 18, 2025

 
ExodusPoint Capital Management, LP
 
 
 
By:
/s/ Timothy Cruise
 
Name:
Timothy Cruise
 
Title:
Authorized Signatory
 
 
 
 
ExodusPoint Capital Partners GP, LLC
 
 
 
By:
/s/ Timothy Cruise
 
Name:
Timothy Cruise
 
Title:
Authorized Signatory
 
 
 
 
Michael Gelband
 
 
 
By:
/s/ Michael Gelband